dihydroxyphenylalanine has been researched along with Asymmetric Diabetic Proximal Motor Neuropathy in 1 studies
Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eldrup, E | 1 |
| Christensen, NJ | 1 |
| Andreasen, J | 1 |
| Hilsted, J | 1 |
1 trial available for dihydroxyphenylalanine and Asymmetric Diabetic Proximal Motor Neuropathy
| Article | Year |
|---|---|
Plasma dihydroxyphenylalanine (DOPA) is independent of sympathetic activity in humans.
Topics: Adult; Aged; Clonidine; Diabetes Mellitus; Diabetic Neuropathies; Dihydroxyphenylalanine; Female; Hu | 1989 |